CSTEVSNRSN• 12 Months (Normalized)
CSTE vs NRSN (Caesarstone Ltd. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Sep 28, 2025 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CSTE Performance $2.79
+86%
Caesarstone Ltd.
Normalized Baseline0.00%
NRSN Performance $7.4
+492%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-406 pts
NRSN outperforming by 406.00 percentage points
CSTENRSN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CSTE NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(248 dates)
| Date | CSTE Price | CSTE Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $2.79 | +86.00% | $7.40 | +492.00% | -406.00% |
| Sep 22, 2026 | $- | $7.18 | +474.40% | - | |
| Sep 21, 2026 | $2.77 | +84.67% | $6.62 | +429.60% | -344.93% |
| Sep 18, 2026 | $2.87 | +91.33% | $6.35 | +408.00% | -316.67% |
| Sep 17, 2026 | $2.81 | +87.33% | $6.72 | +437.60% | -350.27% |
| Sep 16, 2026 | $2.87 | +91.33% | $6.49 | +419.20% | -327.87% |
| Sep 15, 2026 | $3.01 | +100.67% | $7.03 | +462.40% | -361.73% |
| Sep 14, 2026 | $3.13 | +108.67% | $6.90 | +452.00% | -343.33% |
| Sep 11, 2026 | $3.19 | +112.67% | $0.35 | -72.24% | +184.91% |
| Sep 10, 2026 | $3.18 | +112.00% | $0.33 | -73.44% | +185.44% |
| Sep 09, 2026 | $3.01 | +100.67% | $0.40 | -67.92% | +168.59% |
| Sep 08, 2026 | $3.10 | +106.67% | $0.42 | -66.56% | +173.23% |
| Sep 04, 2026 | $2.97 | +98.00% | $0.51 | -59.12% | +157.12% |
| Sep 03, 2026 | $3.05 | +103.33% | $0.40 | -67.84% | +171.17% |
| Sep 02, 2026 | $3.00 | +100.00% | $0.41 | -67.12% | +167.12% |
Page 1 of 17